Sector: Financials
Director information for CHUBB LTD (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| David H. Sidwell | Retired Chief Financial Officer, Morgan Stanley; Chair | 73 | ["Executive Vice President and Chief Financial Officer of Morgan Stanley", "Chief Financial Officer of JPMorgan Chase\u2019s investment bank", "Chartered accountant with the Institute of Chartered Accountants in England and Wales", "Senior Independent Director of UBS Group AG", "Director of the Federal National Mortgage Association (Fannie Mae)", "Background in accounting, finance, and capital markets", "Expertise in risk management", "Experience in executive compensation and corporate governance"] | ["Audit", "Compensation", "Nominating & Governance (Chair)", "Executive", "Nominating & Governance Committee"] | 2026 |
| Evan G. Greenberg | Chairman and Chief Executive Officer | 71 | ["Chairman and Chief Executive Officer of Chubb Limited", "Elected President and Chief Executive Officer in May 2004", "Chairman of the Board of Directors in May 2007", "Joined the company in 2001 as Vice Chairman", "25 years at American International Group, Inc.", "Member of several boards related to international economic affairs", "50 years in the insurance industry"] | ["Executive"] | 2026 |
| Frances F. Townsend | Advisory Services; Chair of the Board | 64 | ["Runs her own independent corporate consulting business", "Former Executive Vice President for Corporate Affairs at Activision Blizzard", "Former Vice Chairman, General Counsel and Chief Administrative Officer at MacAndrews & Forbes Incorporated", "Former partner at the law firm of Baker Botts LLP", "Former Assistant to President George W. Bush for Homeland Security and Counterterrorism", "Former Deputy Assistant to the President and Deputy National Security Advisor for Combating Terrorism", "First Assistant Commandant for Intelligence for the U.S. Coast Guard", "Experience at U.S. Department of Justice in various senior positions", "Board member of the Council on Foreign Relations and the Trilateral Commission"] | ["Executive", "Compensation", "Nominating & Governance", "Nominating & Governance Committee"] | 2026 |
| Fred Hu | Chairman and Chief Executive Officer; Director | 62 | ["Chairman and CEO of Primavera Capital Group since 2010", "Former partner and Chairman of Greater China at Goldman Sachs Group Inc.", "Chairman of the Board of Yum China Holdings Inc.", "Board member of UBS Group AG", "Former co-director of the National Center for Economic Research", "Former professor at Tsinghua University", "Former director of Industrial and Commercial Bank of China Limited", "Former director of Ant Group", "Former director of Hang Seng Bank Limited", "Former director of Hong Kong Exchanges and Clearing Limited", "Former economist at the International Monetary Fund", "Member of the Hong Kong Government\u2019s Strategic Development Committee", "Member of the Advisory Committee for the Hong Kong Securities and Futures Commission", "Doctoral degree in economics from Harvard University"] | ["Risk & Finance"] | 2026 |
| Michael G. Atieh | Retired Chief Financial and Business Officer; Director | 72 | ["Executive Vice President and Chief Financial and Business Officer of Ophthotech Corporation", "Executive Chairman of Eyetech Inc.", "Executive Vice President and Chief Financial Officer of OSI Pharmaceuticals", "Director and Chairman of the Audit Committee of Immatics N.V.", "Director and Chairman of the Audit Committee of Oyster Point Pharma, Inc.", "Member of the Board of Directors of electroCore, Inc.", "Member of the Board of Directors of Theravance Biopharma, Inc.", "Member of the Board of Directors and Chairman of the Audit Committee of OSI Pharmaceuticals, Inc.", "Group President at Dendrite International, Inc.", "Senior Vice President and Chief Financial Officer at Dendrite International, Inc.", "Vice President of U.S. Human Health at Merck & Co., Inc.", "Senior Vice President \u2013 Merck-Medco Managed Care, L.L.C.", "Vice President \u2013 Public Affairs of Merck", "Treasurer of Merck"] | ["Audit", "Risk & Finance", "Audit Committee"] | 2026 |
| Michael L. Corbat | Former Chief Executive Officer, Citigroup Inc. | 65 | ["Nearly 40-year career at Citigroup", "Experience in substantially all of Citi\u2019s business operations", "Former Chief Executive Officer of Europe, Middle East and Africa", "Former Chief Executive Officer of Citi Holdings", "Former Chief Executive Officer of Citi Global Wealth Management", "Experience in financial services, risk management, financial reporting, institutional business, corporate and consumer businesses, employee management, regulatory and compliance, and corporate affairs", "Insight into operational, regulatory, strategic, and international issues"] | ["Audit", "Compensation", "Nominating & Governance", "Nominating & Governance Committee"] | 2026 |
| Michael P. Connors | Independent Lead Director; Chairman and Chief Executive Officer | 70 | ["Founder of Information Services Group, Inc.", "Chairman of the Board", "Chief Executive Officer", "Experience in corporate management", "Expertise in marketing, media and public relations"] | ["Executive", "Audit", "Compensation", "Nominating & Governance", "Nominating & Governance Committee"] | 2026 |
| Nancy K. Buese | Chief Financial Officer; CFO | 56 | ["Chief Financial Officer of CRH plc since May 2025", "Chief Financial Officer of Baker Hughes Company from November 2022 to February 2025", "Executive Vice President and Chief Financial Officer of Newmont Corporation from October 2016 to November 2022", "Executive Vice President and Chief Financial Officer of MPLX", "Former partner with Ernst & Young", "Director of The Williams Companies, Inc. from 2018 to 2023", "Director and audit committee chair of UMB Financial Corporation from 2009 to 2017", "Certified public accountant", "Significant financial and financial reporting knowledge", "More than 25 years in finance leadership roles"] | ["Audit"] | 2026 |
| Nelson J. Chai | Chief Executive Officer, DailyPay, LLC | 60 | ["Chief Executive Officer of DailyPay, LLC since October 2025", "non-executive chairman of DailyPay from January 2025 to October 2025", "Chief Financial Officer of Uber Technologies Inc. from September 2018 to December 2023", "President and Chief Executive Officer of The Warranty Group", "senior management roles at CIT Group, Inc., including President", "senior management positions at Bank of America Corporation and Merrill Lynch & Co.", "Executive Vice President and Chief Financial Officer of NYSE Euronext, Inc.", "served on the board of directors of Thermo Fisher Scientific Inc."] | ["Audit"] | 2026 |
| Olivier Steimer | Former Chairman,Banque Cantonale Vaudoise | 70 | ["Chairman of the Board of Banque Cantonale Vaudoise from October 2002 until December 2017", "Chief Executive Officer, Private Banking International at Credit Suisse Group", "Member of the Group Executive Board at Credit Suisse Group", "Board member of Bank Lombard Odier & Co. Ltd. since January 2018", "Board member of Allreal Holding AG from 2013 to 2025", "Member of the Bank Council of Swiss National Bank from 2009 to 2021, Vice Chairman from 2012 to 2021", "Chairman of the foundation board of the Swiss Finance Institute until June 2017", "Member of the Board of Directors of SBB CFF FFS from 2003, Vice Chairman from 2010 to 2014", "Chairman of the Board of Piguet Galland & Cie SA from 2009 until 2012"] | ["Risk & Finance", "Executive"] | 2026 |
| Robert J. Hugin | Former Chairman and Chief Executive Officer; Director | 71 | ["Former Chief Executive Officer of Celgene Corporation", "Former Chairman of the Board of Directors of Celgene Corporation", "Former Executive Chairman of Celgene Corporation", "Former President of Celgene Corporation", "Former Chief Operating Officer of Celgene Corporation", "Former Senior Vice President and Chief Financial Officer of Celgene Corporation", "Former Managing Director at J.P. Morgan & Co. Inc.", "Director of Biohaven, Ltd.", "Former director of Biohaven Pharmaceutical Holding Company Ltd.", "Former director of Allergan plc", "Former director of Danaher Corporation", "Former director of The Medicines Company"] | ["Risk & Finance"] | 2026 |
| Robert W. Scully | Retired Co-President, Morgan Stanley | 76 | ["Member of the Office of the Chairman of Morgan Stanley from 2007 to 2009", "Co-President of Morgan Stanley", "Chairman of global capital markets", "Vice Chairman of investment banking", "Managing director at Lehman Brothers", "Managing director at Salomon Brothers Inc.", "Director of KKR & Co. Inc.", "Public Governor of the Financial Industry Regulatory Authority (FINRA)", "Director of Zoetis Inc.", "Director of UBS Group AG", "Director of Bank of America Corporation", "Director of GMAC Financial Services", "Director of MSCI Inc.", "Expertise in capital markets activities", "Experience in risk management", "Service on audit committees", "Service on compensation committees", "Service on risk committee", "Service on nominating and governance committee", "Knowledge of talent development", "Experience in strategic initiatives"] | ["Executive", "Audit (Chair)"] | 2026 |
| Sheila P. Burke | Director | [] | [] | 2026 | |
| Theodore E. Shasta | Retired Partner, Wellington Management Company | 75 | ["Chair of Audit Committee", "Senior Vice President and Partner of Wellington Management Company", "Financial analysis of publicly-traded insurance companies", "Chartered Financial Analyst since 1986"] | ["Audit", "Finance and Risk Committee", "Compensation and Governance Committee", "Executive Committee"] | 2026 |
